**Core Concept**
The management of gastric carcinoma, particularly with serosal involvement, requires a multidisciplinary approach considering the stage of the disease, patient's overall health, and the goal of achieving local control with minimal morbidity.

**Why the Correct Answer is Right**
The presence of a 4 cm mass in the antrum with serosal involvement indicates a locally advanced gastric cancer. The standard treatment for such cases involves a combination of neoadjuvant chemotherapy and radiation therapy (chemoradiation) followed by surgical resection. This approach aims to shrink the tumor, improve resectability, and enhance the chances of a curative resection. The use of chemoradiation in locally advanced gastric cancer is supported by clinical trials demonstrating improved survival outcomes.

**Why Each Wrong Option is Incorrect**
**Option A:** Surgical resection alone may not be sufficient to address the serosal involvement, and omitting neoadjuvant chemoradiation may lead to an increased risk of recurrence.
**Option B:** Palliative chemotherapy alone may be considered for patients with advanced disease or those who are not candidates for surgery, but it is not the primary treatment for a resectable, locally advanced gastric cancer.
**Option C:** Radiation therapy alone may not be sufficient to address the tumor's serosal involvement and may not provide adequate local control.

**Clinical Pearl / High-Yield Fact**
The Mandard Tumor Regression Grade (TRG) is a histopathological assessment tool used to evaluate the response of gastric cancer to neoadjuvant chemoradiation. A higher TRG score indicates a better response to treatment.

**Correct Answer: D. Neoadjuvant chemoradiation followed by surgical resection.**